FL
Insider
Foresite Capital Management IV, LLC
10% ownerForesite Capital Management IV, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in Eikon Therapeutics, Inc. (EIKN). Across 1 priced purchase filing, the average 21-session return was -15.7% from execution and -2.0% from disclosure (delay-adjusted; derived). The largest single filing was $1000K of EIKN (55,555 sh × $18.00, as filed), executed Feb 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-15.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-2.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1000K
shares × price, as filed
Last traded
Feb 4
Filed Feb 6
Median ADV $4.4M across their filed names
Open performance→Volume by month
Buys $1000K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EIKNRecent filings
EIKNPURCHASE
Eikon Therapeutics, Inc.
View filing →
$1000K55,555 sh × $18.00
Exec Feb 4
Filed Feb 6 · 7:37 PM ET